Kura Oncology
Rachel Lewis currently serves as Senior Executive Assistant to the Chief Operating Officer and Chief Legal Officer at Kura Oncology, Inc., since March 2024. Prior to this role, Rachel held the position of Executive Assistant to the General Counsel and Chief Accounting Officer at AlloVir from March 2020 to March 2024. Rachel's extensive experience in executive support includes roles at Biogen, where Rachel was involved in various capacities within Worldwide Medical Operations and served as Executive Assistant to the Senior Vice President of Worldwide Medical Affairs. Additional experience includes serving as Operations Manager and Executive Assistant to the CEO at Entasis Therapeutics, Executive Assistant to leadership at AstraZeneca and Novartis, and an early career as Executive Assistant at Intel Corporation and Office Manager at Level One Communications.
This person is not in any teams
This person is not in any offices
Kura Oncology
20 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.